Scarica l'app Stockscreener
131.69
0.63%
0.82
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Precedente Chiudi:
$130.87
Aprire:
$131.32
Volume 24 ore:
612.28K
Relative Volume:
0.57
Capitalizzazione di mercato:
$7.43B
Reddito:
$763.34M
Utile/perdita netta:
$51.40M
Rapporto P/E:
144.97
EPS:
0.9084
Flusso di cassa netto:
$104.46M
1 W Prestazione:
+1.20%
1M Prestazione:
+28.02%
6M Prestazione:
-16.70%
1 anno Prestazione:
+4.44%
Intervallo 1D:
$129.70
$134.11
Intervallo di 1 settimana:
$126.83
$135.72
Portata 52W:
$100.99
$175.77
Repligen Corp Stock (RGEN) Company Profile
Nome
Repligen Corp
Settore
Industria
Telefono
(781) 449-9560
Indirizzo
41 SEYON STREET, WALTHAM, MA
Compare RGEN vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
131.69 | 7.38B | 763.34M | 51.40M | 104.46M | 0.9084 |
ISRG
Intuitive Surgical Inc
|
417.07 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.16 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.84 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.09 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
193.94 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-17 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-01 | Iniziato | HSBC Securities | Buy |
| 2025-09-22 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-29 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Iniziato | Evercore ISI | In-line |
| 2025-02-10 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Iniziato | Canaccord Genuity | Hold |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Iniziato | Guggenheim | Neutral |
| 2023-12-04 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Iniziato | Wells Fargo | Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-03-28 | Iniziato | The Benchmark Company | Buy |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2021-10-14 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-11-01 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Iniziato | SVB Leerink | Outperform |
| 2019-08-28 | Reiterato | First Analysis Sec | Outperform |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2019-07-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Aggiornamento | CL King | Neutral → Buy |
| 2018-11-12 | Downgrade | CL King | Buy → Neutral |
| 2018-09-26 | Iniziato | H.C. Wainwright | Neutral |
| 2017-12-08 | Iniziato | Citigroup | Buy |
| 2017-12-05 | Iniziato | JP Morgan | Overweight |
| 2017-11-13 | Iniziato | CL King | Buy |
| 2017-10-02 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Iniziato | William Blair | Outperform |
| 2017-02-13 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Repligen Corp Borsa (RGEN) Ultime notizie
RBC Capital Resumes Repligen Corp (RGEN) Stock Coverage. Here’s Its View - Insider Monkey
Billionaire Lee Ainslie’s 5 Stocks with Huge Upside Potential - Insider Monkey
Repligen Corp. Hits Day High with 8.45% Surge in Stock Price - Markets Mojo
Multi Cap Equity Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Repligen Corp (RGEN) Shares Surge 3.8% -- What GF Score of 83 Te - GuruFocus
Repligen Corp (RGEN) Shares Surge 4.0% -- What GF Score of 79 Te - GuruFocus
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
State Street Small-Cap Equity V.I.S. Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Repligen Corp at William Blair Growth Stock Conference Transcript - GuruFocus
RGEN Assumed by Wolfe Research -- Rating Upgraded to Outperform - GuruFocus
Wolfe Research initiates Repligen stock coverage with outperform rating By Investing.com - Investing.com Australia
Wolfe Research initiates Repligen stock coverage with outperform rating - Investing.com
Repligen Has A Cleaner Recovery Angle, But With High Valuation - Seeking Alpha
Repligen Corp stock (US7607591002): RGEN jumps after strong Nasdaq session - AD HOC NEWS
Repligen Corp (RGEN) Stock Up 8.4% and Still Undervalued -- GF S - GuruFocus
Repligen's $833 Million Guide: Can Analytics And China Power The Next Leg? - Smartkarma
Repligen Jumps 12% This Week as June Investor Update Approaches - Bez Kabli
Repligen (RGEN) Edges Higher Amid Bioprocessing Sector OptimismFibonacci Arc - The Legal Advocate
Hear Repligen's CEO give company overview at June 3 webcast - Stock Titan
Repligen Corp stock (US7607591002): ESG progress and growth focus draw fresh attention - AD HOC NEWS
InvestingPro’s Fair Value model predicted Repligen’s 45% decline By Investing.com - Investing.com Canada
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks - Yahoo Finance
Repligen’s 2025 Sustainability Report Highlights Carbon Emission Reductions and ESG Progress - geneonline.com
Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report - Yahoo Finance
Repligen Corp (RGEN) Stock Up 4.2% and Still Undervalued -- GF S - GuruFocus
Repligen shares jump 4.1% as investors buy the dip after a sharp selloff; prior guidance update and short-covering may be factors - Quiver Quantitative
Repligen Jumps 5.4% Amid Sector-Wide Rally - AlphaStreet
Why Repligen (RGEN) Stock Is Trading Up Today - Yahoo Finance
Repligen (RGEN) director granted RSUs and options in Form 4 filing - Stock Titan
Repligen (NASDAQ: RGEN) director receives new RSU and stock option awards - Stock Titan
Repligen (RGEN) director Rohin Mhatre receives RSU and option grants - Stock Titan
Repligen (RGEN) director Margaret Pax receives new RSU and stock option awards - Stock Titan
Repligen (NASDAQ: RGEN) director granted RSUs and options in equity award - Stock Titan
Repligen (RGEN) director receives new RSU and stock option grants - Stock Titan
Repligen Corp stock (US7607591002): bioprocessing specialist back in focus after latest earnings - AD HOC NEWS
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know - Yahoo Finance
Repligen Corp stock (US7607591002): RBC upgrade and Q1 2026 earnings put bioprocessing specialist ba - AD HOC NEWS
BNY Mellon Mid Cap Multi-Strategy Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Repligen Corp. 2026 Annual Meeting Results: Voting Outcomes & Key Shareholder Decisions - Minichart
Repligen shareholders approve board nominees and executive pay at annual meeting - Investing.com
Repligen (NASDAQ: RGEN) holders back board, auditor and pay plan - Stock Titan
5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call - Yahoo Finance
Repligen Corporation (RGEN) Q1 2026 Earnings Beat: Revenue $N/A, EPS $0.48Special Dividend Alert - The Legal Advocate
Repligen (RGEN) Receives Positive Coverage from RBC Capital - GuruFocus
Repligen stock coverage resumed at RBC with outperform rating By Investing.com - Investing.com Nigeria
Repligen stock coverage resumed at RBC with outperform rating - Investing.com
Repligen Corp stock (US7607591002): bioprocessing specialist after earnings and 52?week low - AD HOC NEWS
Repligen Corp Azioni (RGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Repligen Corp Azioni (RGEN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Loeillot Olivier | Chief Executive Officer |
Apr 21 '26 |
Sale |
140.00 |
3,832 |
536,480 |
54,246 |
1.68%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):